top of page
At the March 2024 Society of Toxicology (SOT) meeting, Exir Bio presented how it is changing the way the industry handles primate use for drug efficacy and safety testing.
If you missed the presentation, you can still receive it here!
Bridging the gap between human and mouse
Exir Bio's proprietary technology uses primate stem cells to create reproducible, ethical, and clinically relevant preclinical testing solutions.
13x
increase in per-monkey acquisition cost since 2019
“Attitudes towards experimenting on monkeys are diverging. Many countries are growing warier, even as China races ahead.”
The Economist, July 2021
428 Oakmead Pkwy, Sunnyvale, CA 94085
Products
Applications
Company
© 2024 Exir Bio. All Rights Reserved.
bottom of page